menu
    • menu

    Company profile for Flamingo Therapeutics

    NEW Drugs in Dev.: 1
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our company was built upon our deep experience and know-how in RNA therapeutics and we are well-positioned to advance candidates against targets considered “undruggable”, using RNA chemistries. We are focused on advancing our clinical pipeline for large unmet oncology indications where we believe RNA-targeting can be successful.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Flamingo TherapeuticsBelgium Flag
    Country
    Country
    Belgium
    Address
    Address
    Gaston Geenslaan 1 3001 Leuven
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://flamingotx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/flamingo-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Flamingo Therapeutics Presents at AACR Special Cancer Conference
    Flamingo Therapeutics Presents at AACR Special Cancer Conference

    14 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/flamingo-therapeutics-announces-oral-presentation-at-aacr-special-conference-in-cancer-research-on-rnas-as-drivers-targets-and-therapeutics-in-cancer-302305011.html

    PR NEWSWIRE
    14 Nov 2024
    Share Share
    Flamingo Highlights MALAT1 Inhibitor FLM-7523 At EACR 2024
    Flamingo Highlights MALAT1 Inhibitor FLM-7523 At EACR 2024

    10 Jun 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/flamingo-therapeutics-announces-poster-presentation-at-eacr-2024-congress-on-flm-7523-ftx-001-a-first-in-class-inhibitor-of-the-long-non-coding-rna-malat1-302167874.html

    PR NEWSWIRE
    10 Jun 2024
    Share Share
    Flamingo Therapeutics Appoints Leading Medical Oncologist Ezra Cohen as MD
    Flamingo Therapeutics Appoints Leading Medical Oncologist Ezra Cohen as MD

    21 Mar 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/flamingo-therapeutics-appoints-leading-medical-oncologist-ezra-cohen-md-to-its-board-of-directors-302095070.html

    PR NEWSWIRE
    21 Mar 2024
    Share Share
    Flamingo Announces Appointment of Andrew E. Denker, MD, PhD, as CMO
    Flamingo Announces Appointment of Andrew E. Denker, MD, PhD, as CMO

    04 Apr 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/flamingo-therapeutics-announces-appointment-of-andrew-e-denker-md-phd-as-chief-medical-officer-301789459.html

    PR NEWSWIRE
    04 Apr 2023
    Share Share
    Flamingo Therapeutics and Dynacure Announce Merger
    Flamingo Therapeutics and Dynacure Announce Merger

    02 Mar 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/flamingo-therapeutics-and-dynacure-announce-merger-to-create-leading-rna-therapeutics-company-focused-on-clinical-oncology-301760437.html

    PR NEWSWIRE
    02 Mar 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search